EXPIRED
January 6, 2022
PAR-22-093, Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
PAR-22-094, Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
National Institute on Aging (NIA)
This Notice of Special Interest (NOSI) highlights priority areas of dementia care research other than intervention development. Applications focused solely on unpaid dementia care partners/caregivers may cite NOT-AG-21-047, and applications focused on the paid dementia care workforce may cite NOT-AG-21-049 in the Agency Routing Identifier field (box 4B). PLEASE NOTE: Applications proposing clinical trials will not be considered a high priority for this NOSI. Studies proposing dementia care intervention research are encouraged to explore whether PAR-21-307 Dementia Care and Caregiver Support intervention Research (R01- Clinical Trial Required) or PAR-21-308 Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required) would be more appropriate.
This NOSI invites applications on high-priority Alzheimer's disease (AD) and AD-related dementias (ADRD) care research areas as set forth by the National Institute on Aging’s Division of Behavioral and Social Research. The NOSI is based on expert discussions from the NIH 2020 Dementia Care Summit, the NASEM Decadal Survey of Behavioral and Social Science Research on AD/ADRD, and is aligned with AD/ADRD research implementation milestones.
In addition to affecting the health and well-being of individual patients and families, AD/ADRD has a significant impact on medical and social service systems. Persons living with dementia (PLWD) may experience issues with continuity of care as well as expensive, but variable and ineffective, health care and long-term services and supports (LTSS). If these issues are unaddressed, these problems will worsen as the number of PLWD increases. This NOSI encourages research on the care of persons living with dementia as well as the systems and the individuals within those systems that provide care to PLWD.
There is a need for research to better understand the outcomes associated with various forms and levels of care of PLWD across disease stages, etiologies, and dementia care settings, as well as the experience and consequences of care for PLWD. Research areas of interest include the following:
For burden of disease factors, research is needed that extends beyond broad societal costs to examine the entire distribution of individuals affected by the disease in addition to population averages. Research areas of interest include the following:
Research to elucidate disparities in the amount and quality of care provided, and disparities in the access to care and services with an emphasis on developing valid and reliable measures in these areas is strongly encouraged.
More research is needed to understand community support for dementia care. Research areas of interest include the following:
In addition, studies are encouraged in the following high-priority topic areas including, but not limited to, the following:
Applications considered high priority should propose research involving secondary data analysis, new data collection and data linkages, and/or measurement development, with an emphasis on variables relevant to persons living with dementia (person-centered perspective), paid care providers, communities, and systems providing care. Applications that solely document descriptive trends without addressing potential mechanisms or explanations will not be considered a high priority, nor will applications that focus solely on caregivers or care partners without considering outcomes for PLWD.
Application and Submission Information
This notice applies to due dates on or after March 11, 2022 and subsequent receipt dates through November 13, 2024.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice:
PAR-22-094, Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:
Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.